Performance evaluation of the Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA, a 4th generation HIV assay for the simultaneous detection of HIV p24 antigen and antibodies to HIV-1 (groups M and O) and HIV-2 in human serum or plasma

Journal of Clinical Virology

Volumn 52, Issue SUPPL. 1, 2011, Pages

  Bentsen, Christopher ^a   McLaughlin, Lisa ^a   Mitchell, Elizabeth ^a   Ferrera, Carol ^a   Liska, Sally ^b   Myers, Robert ^c   Peel, Sheila ^d   Swenson, Paul ^e   Gadelle, Stephane ^f   Shriver, M Kathleen ^a  

^a BIO RAD LABORATORIES   (United States)

^b SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

^c MARYLAND DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^d WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^e PUBLIC HEALTH SEATTLE AND KING COUNTY   (United States)

^f Bio Rad   (France)

Author keywords

4th generation; Acute; Antibody; Combination; HIV antigen

Indexed keywords

ANTIGEN P24; HUMAN IMMUNODEFICIENCY VIRUS 1 ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS 2 ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BLOOD SAMPLING; DIAGNOSTIC KIT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEROCONVERSION;

HIV ANTIBODIES; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HIV-2; HUMANS; IMMUNOENZYME TECHNIQUES; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PLASMA; REAGENT KITS, DIAGNOSTIC; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SERUM; UNITED STATES;

EID: 83155181507     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2011.09.023     Document Type: Article

References (21)

1. Centers for Disease Control Provisional Public Health Service interagency recommendations for screening donated blood and plasma for antibody to the virus causing acquired immunodeficiency syndrome. MMWR 1985, 34:5-7.
2. Barre-Sinoussi F., Chermann J.C., Rey F., Nugeyre M.T., Chamaret S., Gruest J., et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983, 220:868-871.
3. Gallo R.C., Salahuddin S.Z., Popovic M., Shearer G.M., Kaplan M., Haynes B.F., et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 1984, 224:500-503.
4. Coffin J., Haase A., Levy J.A., Montagnier L., Oroszlan S., Teich N., et al. What to call the AIDS virus?. Nature 1986, 321:10.
5. Clavel F., Guetard D., Brun-Vezinet F. Isolation of a new human retrovirus from West African patients with AIDS. Science 1986, 233:343-346.
6. Clavel F., Manshino K., Chameret S., Guetard D., Favier V., Nina J., et al. Human immunodeficiency virus type 2 infection associated with AIDS in West Africa. N Engl J Med 1987, 316:1180-1185.
7. Centers for Disease Control AIDS due to HIV-2 infection - New Jersey. MMWR 1988, 37:33-35.
8. Hoff R., Weiblen B.J., Schwerzler M., Werner B., Krieger M.S., McClure J., et al. Specific antibodies to HIV-2 detected in an anonymous newborn blood specimen from Massachusetts. Presented at the Fourth Consensus Conference on Testing for Human Retroviruses 1989.
9. Ayanian J.Z., Maguire J.H., Marlink R.G., Essex M., Kanki P.J. HIV-2 infection in the United States. N Engl J Med 1989, 320:1422-1423.
10. O'Brien T.R., George J.R., Holmberg S.D. Human immunodeficiency virus type 2 infection in the United States. JAMA 1992, 267:2775-2779.
11. Sullivan M.T., Guido E.A., Metler R.P., Schable C.A., Williams A.E., Stramer S.L. Identification and characterization of an HIV-2 antibody-positive blood donor in the United States. Transfusion 1998, 38:189-193.
12. Sullivan P.S., Fleming P.L. Surveillance for HIV-2 in the United States: update and recommendations for future surveillance. Presented at the Association of Public Health Laboratories Conference 2000.
13. Janssens W., Buvé A., Nkengasong J.N. The puzzle of HIV-1 subtypes in Africa. AIDS 1997, 11:705-712.
14. Charneau P., Borman A.M., Quillant C., Guetard D., Chamaret S., Cohen J., et al. Isolation and envelope sequence of a highly divergent HIV-1 isolate: definition of a new HIV-1 group. Virology 1994, 205:247-253.
15. Simon F., Mauclère P., Rogues P., Loussert-Ajaka I., Muller-Trutwin M.C., Saragosti S., et al. Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat Med 1998, 4:1032-1037.
16. Gao F., Yue L., Robertson D.L., Hill S.C., Hui H., Biggar R.J., et al. Genetic diversity of human immunodeficiency virus type 2: evidence for distinct subtypes with differences in virus biology. J Virol 1994, 68:7433-7447.
17. Courouce A.M., Barin F., Maniez M., Janot C., Noel L., Elghouzzi M.H. Effectiveness of assays for antibodies to HIV and p24 antigen to detect very recent HIV infections in blood donors. AIDS 1992, 6:1548-1550.
18. Busch M.P., Lee L.L., Satten G.A., Henrard D.R., Farzadegan H., Nelson K.E., et al. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Transfusion 1995, 35:91-97.
19. Owen S.M., Yang C., Spira T., Ou C.Y., Pau C.P., Parekh B.S., et al. Alternative Algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the United States. J Clin Microbiol 2008, 46(May (5)):1588-1595.
20. Centers for Disease Control Acute HIV infection - New York City, 2008. MMWR 2009, 58(46):1296-1299.
21. Brenner B.G., Roger M., Routy J.P., Moisi D., Ntemgwa M., Matte C., et al. High Rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis 2007, 195:951-959.